Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.70p
   
  • Change Today:
    -0.100p
  • 52 Week High: 7.10
  • 52 Week Low: 2.85
  • Currency: UK Pounds
  • Shares Issued: 274.89m
  • Volume: 690,021
  • Market Cap: £10.17m
  • RiskGrade: 304

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
6.16% below the market average6.16% below the market average6.16% below the market average6.16% below the market average6.16% below the market average
48.28% above the sector average48.28% above the sector average48.28% above the sector average48.28% above the sector average48.28% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
13.28% above the market average13.28% above the market average13.28% above the market average13.28% above the market average13.28% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Price Chg 3m
65.51% below the market average65.51% below the market average65.51% below the market average65.51% below the market average65.51% below the market average
26.98% below the sector average26.98% below the sector average26.98% below the sector average26.98% below the sector average26.98% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
40.00% above the market average40.00% above the market average40.00% above the market average40.00% above the market average40.00% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
Momentum 20
24.76% above the market average24.76% above the market average24.76% above the market average24.76% above the market average24.76% above the market average
30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
53.61% below the market average53.61% below the market average53.61% below the market average53.61% below the market average53.61% below the market average
1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
65.1% below the market average65.1% below the market average65.1% below the market average65.1% below the market average65.1% below the market average
10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
40.29% below the market average40.29% below the market average40.29% below the market average40.29% below the market average40.29% below the market average
22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average
Cash
32.52% below the market average32.52% below the market average32.52% below the market average32.52% below the market average32.52% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Evgen Pharma Market Data

Currency UK Pounds
Share Price 3.70p
Change Today -0.100p
% Change -2.63 %
52 Week High 7.10
52 Week Low 2.85
Volume 690,021
Shares Issued 274.89m
Market Cap £10.17m
RiskGrade 304

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
7.62% below the market average7.62% below the market average7.62% below the market average7.62% below the market average7.62% below the market average
55.93% above the sector average55.93% above the sector average55.93% above the sector average55.93% above the sector average55.93% above the sector average
Price Trend
30.45% above the market average30.45% above the market average30.45% above the market average30.45% above the market average30.45% above the market average
52.38% above the sector average52.38% above the sector average52.38% above the sector average52.38% above the sector average52.38% above the sector average
Income Not Available
Growth Not Available

Evgen Pharma Dividends

No dividends found

Trades for 30-Mar-2023

Time Volume / Share Price
16:22 53,702 @ 3.69p
13:52 583 @ 3.80p
13:33 35,000 @ 3.67p
13:20 54 @ 3.69p
12:39 300,000 @ 3.53p

Evgen Pharma Key Personnel

CFO Richard Moulson
CEO Huw Jones

Top of Page